NCT01463371View on ClinicalTrials.gov

Effects of Azithromycin on Airway Oxidative Stress Markers in Patients With Bronchiectasis

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

September 30, 2007

Conditions
Bronchiectasis
Interventions
DRUG

Azithromycin

250 mg three times a week during three months

Trial Locations (1)

46026

University Hospital La Fe, Valencia

All Listed Sponsors
collaborator

Sociedad Valenciana de Neumología

UNKNOWN

lead

Instituto de Investigacion Sanitaria La Fe

OTHER

NCT01463371 - Effects of Azithromycin on Airway Oxidative Stress Markers in Patients With Bronchiectasis | Biotech Hunter | Biotech Hunter